UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC APP 47163/2024

Aug 14, 2024·EP3666797: ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Case details
Status
Written Phase
Action
Generic
Category
Document Access (RoP262)
Parties
Claimants
Reps: Daniel Wise
Respondents
Reps: Koen Bijvank
Division
Munich CD
Judges
Technology
Biotechnology
Language
English
First decided
Oct 22, 2024
Decisions
  • 2024-10-22
    Application RoP262.1 (b)

    Order from the Central Division Munich (UPC_CFI_1/2023) on Dehns' application under R. 262.1(b) RoP for access to all written pleadings and evidence in the combined revocation and counterclaim for revocation proceedings (Sanofi v Amgen, EP 3 666 797). The Court granted partial access to case documents, subject to conditions proposed by Sanofi, to enable Dehns, a firm of UPC representatives, to better understand the Court's procedures.

    Legal issues:Third-party access to court documents (R. 262.1(b) RoP)Public interest in transparency of UPC proceedings
Documents
Document titleDatePublic
Procedural Order App_47163/20242024-10-23Not public
Headnote-and-Keywords2024-10-22Not public
Outcome of the Order2024-10-22Not public
262.1(b) order2024-10-22Public
262.1(b) order2024-10-22Not public
262.1(b) order2024-10-22Not public
opportunity to comment for applicant2024-09-10Not public
US Delaware District Court Memorandum Order2024-08-29Not public
2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed2024-08-29Not public
2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed2024-08-29Not public
US Delaware District Court Memorandum Order2024-08-29Not public
2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed2024-08-29Not public
US Delaware District Court Memorandum Order2024-08-29Not public
Reply to RoP 262.1 (b)2024-08-22Not public
Opportunity to comment2024-08-15Not public
Access Request under RoP262.1(b)2024-08-14Not public